Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
94.11
-0.30 (-0.32%)
At close: Dec 27, 2024, 4:00 PM
94.45
+0.34 (0.36%)
After-hours: Dec 27, 2024, 5:07 PM EST

Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $117.29 billion as of December 27, 2024. Its market cap has increased by 13.28% in one year.

Market Cap
117.29B
Enterprise Value
133.84B
1-Year Change
13.28%
Ranking
Category
Stock Price
$94.11

Market Cap Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $117.29B, an increase of 11,952.83%. That is a compound annual growth rate of 20.16%.

History

DateMarket Cap% Change
Dec 27, 2024117.29B16.19%
Dec 29, 2023100.94B-6.25%
Dec 30, 2022107.68B18.22%
Dec 31, 202191.08B24.72%
Dec 31, 202073.03B-11.17%
Dec 31, 201982.21B1.60%
Dec 31, 201880.92B-13.53%
Dec 29, 201793.58B-0.81%
Dec 30, 201694.34B-35.31%
Dec 31, 2015145.83B2.55%
Dec 31, 2014142.21B23.49%
Dec 31, 2013115.15B106.93%
Dec 31, 201255.65B81.01%
Dec 30, 201130.74B4.49%
Dec 31, 201029.42B-24.44%
Dec 31, 200938.94B-16.37%
Dec 31, 200846.56B8.73%
Dec 31, 200742.82B43.43%
Dec 29, 200629.86B24.03%
Dec 30, 200524.07B58.92%
Dec 31, 200415.15B28.36%
Dec 31, 200311.80B76.49%
Dec 31, 20026.69B6.07%
Dec 31, 20016.30B61.59%
Dec 29, 20003.90B64.05%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Amgen 142.17B
Stryker 141.35B
Boston Scientific 134.22B
Sanofi 119.50B
Bristol-Myers Squibb Company 117.15B
Vertex Pharmaceuticals 105.12B
Medtronic 104.56B
Elevance Health 86.49B
Market Cap Rankings